Expression of vascular endothelial growth factor C in human pterygium (Q44050914)

29 November 2017

Expression of vascular endothelial growth factor C in human pterygium (English)

1 reference

29 November 2017

Junichi Fukuhara

1

1 reference

29 November 2017

Satoru Kase

2

1 reference

29 November 2017

Tsutomu Ohashi

3

1 reference

29 November 2017

Ryo Ando

4

1 reference

29 November 2017

Zhenyu Dong

5

1 reference

29 November 2017

Kousuke Noda

6

1 reference

29 November 2017

Takeshi Ohguchi

7

1 reference

29 November 2017

Atsuhiro Kanda

8

1 reference

29 November 2017

Susumu Ishida

9

1 reference

29 November 2017

23 August 2012

1 reference

Histochemistry and Cell Biology

29 November 2017

1 reference

29 November 2017

139

1 reference

29 November 2017

2

1 reference

29 November 2017

381-389

1 reference

https://scigraph.springernature.com/pub.10.1007/s00418-012-1019-z

29 November 2017

0 references

cites work

Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4)

1 reference

https://api.crossref.org/works/10.1007%2FS00418-012-1019-Z

Proliferative and migratory aptitude in pterygium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00418-012-1019-Z

Ophthalmic pterygium: a stem cell disorder with premalignant features

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00418-012-1019-Z

RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00418-012-1019-Z

Differential expression of vascular endothelial growth factor implies the limbal origin of pterygia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00418-012-1019-Z

Inhibition of cyclooxygenase-2 suppresses lymph node metastasis via reduction of lymphangiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00418-012-1019-Z

Vascular endothelial growth factor-D and its receptor VEGFR-3: two novel independent prognostic markers in gastric adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00418-012-1019-Z

Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00418-012-1019-Z

Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00418-012-1019-Z

Immunolocalisation of E-cadherin and beta-catenin in human pterygium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00418-012-1019-Z

Expression of p27(KIP1) and cyclin D1, and cell proliferation in human pterygium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00418-012-1019-Z

VEGF-C promotes the development of esophageal cancer via regulating CNTN-1 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00418-012-1019-Z

Vascular endothelial growth factor receptor-3 in lymphangiogenesis in wound healing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00418-012-1019-Z

Differential response of primary tumor versus lymphatic metastasis to VEGFR-2 and VEGFR-3 kinase inhibitors cediranib and vandetanib

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00418-012-1019-Z

Microsatellite instability and loss of heterozygosity in human pterygia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00418-012-1019-Z

VEGFR-3 in adult angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00418-012-1019-Z

Combined blockade of VEGFR-2 and VEGFR-3 inhibits inflammatory lymphangiogenesis in early and middle stages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00418-012-1019-Z

VEGF-C and VEGF-D expression in neuroendocrine cells and their receptor, VEGFR-3, in fenestrated blood vessels in human tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00418-012-1019-Z

Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00418-012-1019-Z

Down-regulation of vascular endothelial cell growth factor-C expression using small interfering RNA vectors in mammary tumors inhibits tumor lymphangiogenesis and spontaneous metastasis and enhances survival

21 January 2018

1 reference

12 December 2020

Preliminary evidence of the presence of lymphatic vessels immunoreactive for D2-40 and Prox-1 in human pterygium

1 reference

12 December 2020

The role of the lymphatic system and its specific growth factor, vascular endothelial growth factor C, for lymphogenic metastasis in prostate cancer

1 reference

12 December 2020

Tumor lymphangiogenesis in transitional cell carcinoma of the upper urinary tract: association with clinicopathological features and prognosis

1 reference

12 December 2020

A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases

1 reference

12 December 2020

VEGF-C, VEGF-D and Flt-4 in transitional bladder cancer: relationships to clinicopathological parameters and long-term survival

1 reference

12 December 2020

Vascular endothelial growth factors C and D represent novel prognostic markers in colorectal carcinoma using quantitative image analysis

1 reference

12 December 2020

A randomized controlled trial of intralesional bevacizumab injection on primary pterygium: preliminary results

1 reference

12 December 2020

Lymphatic spread is related to VEGF-C expression and D2-40-positive myofibroblasts in intrahepatic cholangiocarcinoma

1 reference

12 December 2020

Lymphatic vessels in vascularized human corneas: immunohistochemical investigation using LYVE-1 and podoplanin

1 reference

12 December 2020

Cyclooxygenase 2 expression in pterygium.

1 reference

12 December 2020

10.1007/S00418-012-1019-Z

Identifiers

DOI

1 reference

29 November 2017

1 reference